Alexander Aravanis M.D., Ph.D.
Net Worth
Last updated:
What is Alexander Aravanis M.D., Ph.D. net worth?
The estimated net worth of Dr. Alexander Aravanis M.D., Ph.D. is at least $8,228,432 as of 22 Feb 2023. He owns shares worth $296,875 as insider, has earned $6,265,637 from insider trading and has received compensation worth at least $1,665,920 in Illumina, Inc..
What is the salary of Alexander Aravanis M.D., Ph.D.?
Dr. Alexander Aravanis M.D., Ph.D. salary is $416,480 per year as Chief Technology Officer & Head of Research and Product Devel. in Illumina, Inc..
What stocks does Alexander Aravanis M.D., Ph.D. currently own?
As insider, Dr. Alexander Aravanis M.D., Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Illumina, Inc. (ILMN) | Chief Technology Officer & Head of Research and Product Devel. | 2,922 | $101.6 | $296,875 |
What does Illumina, Inc. do?
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
Alexander Aravanis M.D., Ph.D. insider trading
Illumina, Inc.
Dr. Alexander Aravanis M.D., Ph.D. has made 10 insider trades between 2021-2023, according to the Form 4 filled with the SEC. Most recently he sold 2,320 units of ILMN stock worth $469,011 on 22 Feb 2023.
The largest trade he's ever made was exercising 9,292 units of ILMN stock on 21 Feb 2023. As of 22 Feb 2023 he still owns at least 2,922 units of ILMN stock.